Screening Tests vs. Diagnostic Tests During Pregnancy

A Clearer Picture During Pregnancy

Prenatal testing can offer information about a baby’s health and help guide conversations about care during pregnancy or after birth. These tests are optional, and choosing whether to have them is a personal decision.

The options answer different questions. Screening estimates the chance of certain conditions; it does not confirm that a condition is present. Diagnostic testing examines fetal or placental material to seek a more definitive answer about the specific conditions tested. A higher-risk screening result is not a diagnosis, and your clinician can explain whether follow-up testing may be appropriate. ACOG’s guidance on prenatal genetic screening explains this distinction.

Which tests may suit you, and when they are offered, can depend on your pregnancy, health and family history, and personal preferences. At raveco.com, obstetrics and gynecology care in Queens is centered on personalized support, giving patients space to discuss what a test can and cannot show. Ask your prenatal care provider about possible benefits, limitations, and next steps so you can make an informed choice that feels right for you.

Screening Estimates Risk, Diagnosis Seeks Answers

Prenatal screening and diagnostic tests answer different questions. Screening uses approaches such as blood tests and ultrasound to estimate the chance of certain chromosome conditions or birth defects. It does not confirm that a condition is present. For a fuller explanation of how screening differs from diagnosis, ask your prenatal care team what each test is designed to assess.

A higher-risk screening result is not a diagnosis, and a lower-risk result does not rule out every condition. False-positive results can suggest a risk when the condition is not present; false-negative results can miss a condition. Accuracy varies by test, so a clinician can explain what a particular result means and whether follow-up is worth considering. ACOG’s guidance on prenatal genetic screening also stresses that screening estimates chance rather than certainty.

Diagnostic testing offers a more definitive assessment of the specific conditions tested for. Chorionic villus sampling (CVS) collects placental tissue, while amniocentesis collects fluid surrounding the fetus. Because these procedures involve sampling tissue or fluid, they are more invasive than screening and carry some risk. A clinician can discuss their potential benefits and risks in the context of an individual pregnancy.

Neither screening nor diagnostic testing can detect every condition or predict every possible outcome. Results also may not show how a condition would affect a child. At Raveco, prenatal care is provided through a women-led obstetrics and gynecology practice in Queens, where patients can discuss questions and testing choices with their care team.

Testing is optional. A clinician or genetic counselor can explain what a test can and cannot determine, review personal and family health history, and help a patient weigh the information against their preferences. The decision belongs to the patient, whether they choose screening, diagnostic testing, or neither.

How Prenatal Tests Fit Into Care

Prenatal care includes routine checks on the pregnant person’s health as well as tests that assess fetal development. Early visits commonly include a complete blood count, blood typing and Rh-factor testing, urine testing and culture, and screening for infections such as HIV, hepatitis B and C, and syphilis. Testing may also check immunity to rubella. These routine checks are distinct from genetic screening; ACOG’s guide to routine tests during pregnancy explains what they can detect.

There is no standard number of blood draws for everyone. Several tests may be run from one sample, while additional or repeat samples may be needed based on results, health history, and other clinical circumstances. At raveco.com, prenatal care is provided through a women-led obstetrics and gynecology practice in Queens, where patients can discuss which checks fit their individual care.

Some screening and diagnostic options are tied to particular stages of pregnancy, but timing can vary. Cell-free DNA screening may begin at about 10 weeks, and first-trimester screening often combines a blood test with an ultrasound measurement called nuchal translucency around weeks 11 to 13. Chorionic villus sampling (CVS), a diagnostic procedure, is generally performed around weeks 10–13. A clinician can explain what each option assesses and whether it is appropriate.

The quad screen is generally offered in the second trimester, though the recommended window varies by guidance and practice. It measures substances in maternal blood to estimate the risk of selected chromosome conditions and neural tube defects. The anatomy ultrasound, commonly performed around 18 to 20 weeks, with some guidance placing it as late as 22 weeks, examines fetal structures. It is an imaging assessment, not a genetic diagnostic test. Johns Hopkins describes common pregnancy tests and their purposes.

Gestational diabetes screening is usually offered at 24 to 28 weeks. Group B streptococcus screening is typically done late in pregnancy, around 35 to 37 weeks. Both are routine pregnancy screens, not genetic diagnostic tests. Your clinician can confirm the timing and recommended tests, taking into account your pregnancy history, previous results, and individual circumstances.

What Cell-Free DNA Screening Can Show

Cell-free DNA screening, often called NIPT, is a blood test that examines small fragments of placental DNA circulating in the pregnant person’s blood. It is generally available from about 10 weeks of pregnancy, though a clinician can confirm timing for an individual pregnancy. ACOG explains that cell-free DNA screens for selected chromosome differences.

The test commonly estimates the chance of trisomy 21, also known as Down syndrome, trisomy 18, and trisomy 13. Depending on the panel, it may also assess sex chromosome differences and provide information about fetal sex. NIPT does not test for every genetic condition or birth difference, so a result should be understood in light of what the specific panel includes.

An increased-risk result is not a diagnosis. It may prompt a conversation about whether diagnostic testing, such as chorionic villus sampling or amniocentesis, would be useful. A prenatal clinician can explain what the result means, discuss the available follow-up, and help weigh options in the context of the pregnancy. Raveco provides personalized obstetric and gynecologic care in Queens, where patients can discuss testing questions with their pregnancy care team.

Because screening is optional and its scope is limited, it may help to ask which conditions the test covers and what next steps could follow each possible result. ACOG’s guidance on prenatal genetic diagnostic tests explains how diagnostic testing differs from screening.

Conditions Different Tests May Assess

The conditions a prenatal test can assess depend on what it examines. Screening and diagnostic tests may address chromosome conditions such as Down syndrome (trisomy 21), trisomy 18, and trisomy 13, as well as certain other chromosome changes. Some tests can assess missing or extra chromosome segments, but the available tests and their scope vary. ACOG’s guidance on prenatal genetic diagnostic tests explains what these tests can and cannot establish.

Carrier screening asks a different question: it checks a parent or prospective parent for gene changes associated with inherited conditions, including cystic fibrosis, spinal muscular atrophy, and sickle cell disease. It can be done before conception or during pregnancy. If one partner is found to be a carrier, testing the other partner may help assess the chance of the condition in a pregnancy. An OB-GYN or genetic counselor can explain which options fit a person’s health history and preferences.

Some maternal blood tests and ultrasound assessments look for signs associated with physical differences, including open neural tube defects such as spina bifida. These findings are not the same as identifying a genetic condition, and an ultrasound or blood screening result does not confirm a diagnosis.

An abnormal screening result estimates an increased chance of a condition; it does not establish that the fetus has it. A clinician may offer diagnostic testing to clarify the result. No prenatal test covers every condition, so ask what a particular test assesses and what its limits are. At raveco.com, prenatal care is provided through a women-led obstetrics and gynecology practice in Queens, where patients can discuss testing questions with their care team.

Weighing Information Against Procedure Risks

Prenatal testing may offer information that helps patients and care teams consider pregnancy management, prepare for a baby’s medical needs, or plan for care around birth. Some findings may also help identify conditions for which treatment during pregnancy or soon after birth could be useful. The value of testing depends on what a patient wants to know and how the information may guide care.

Screening estimates the chance of selected conditions; it does not confirm that a condition is present. A false-positive result can suggest a risk that is not present, while a false-negative result may miss a condition. Tests also differ in what they assess, so a result cannot rule out every health concern. A clinician can explain the limits of a specific test and whether follow-up may be appropriate, as described in Mayo Clinic’s overview of prenatal testing.

Chorionic villus sampling (CVS) and amniocentesis examine placental or amniotic-fluid samples and can provide more definitive information about particular genetic or chromosomal conditions. They cannot answer every question about fetal health, and a negative result applies only to the conditions tested. Results may still leave uncertainty about how a condition could affect a child.

These procedures carry a small risk of pregnancy loss. Other possible complications include bleeding or infection, and amniocentesis may cause fluid leakage. The likelihood of complications varies by procedure and individual circumstances, so patients can ask their clinician to explain the risks in their situation. The American College of Obstetricians and Gynecologists’ guidance on prenatal diagnostic tests also notes that testing cannot identify every genetic condition.

Testing is optional. A patient may choose screening, diagnostic testing, both, or neither, based on personal values and the information they want. At raveco.com, pregnancy care is provided through personalized obstetrics and gynecology services in Queens, where patients can discuss testing choices and questions with their care team.

Choosing Not to Have Genetic Screening

Prenatal genetic screening, including NIPT, is optional. Choosing not to test is a valid personal decision, and patients can decline screening or decide not to pursue follow-up testing after discussing their options with a clinician. ACOG notes that testing choices reflect each person’s values and preferences.

Someone may decide that results would not change pregnancy or care decisions, or prefer not to face uncertainty or stress from a higher-risk result that may need clarification. Personal, cultural, or religious values may also shape a preference not to learn about possible conditions before birth.

Concerns about diagnostic follow-up, procedure risks, cost, or insurance coverage can matter too. Coverage varies by plan and test, so patients can ask their insurer and care team about possible costs. At Raveco Medical, prenatal care is personalized to each patient, supporting a respectful conversation about what tests can reveal, possible next steps, and the patient’s priorities.

Planning for Costs and Coverage

Insurance coverage for prenatal genetic testing varies by plan, test, and individual medical history or pregnancy risk factors. A test recommended for one patient may not be covered for another, so confirm benefits before scheduling.

Ask your insurer whether the test is covered, whether you must use an in-network laboratory, whether prior authorization is needed, and what you may owe out of pocket. Your provider’s office or the testing laboratory may be able to help verify benefits. Coverage questions can also be part of a broader conversation about costs and coverage.

If coverage is unavailable or leaves a substantial balance, ask the laboratory about self-pay pricing or financial assistance. Before deciding, review the test’s purpose, timing, limitations, possible follow-up, and cost with your prenatal care team. At raveco.com, prenatal care is personalized, making it a setting to discuss testing choices in the context of your pregnancy and concerns.

Make the Choice With Your Care Team

Screening estimates the chance of certain conditions, while diagnostic testing can provide a more definite answer about the conditions tested. Neither option is right for every pregnancy, and choosing no testing is also a valid decision. ACOG’s guidance on prenatal genetic testing emphasizes that the choice is personal.

Before deciding, ask what a recommended test can and cannot assess, when it is offered, and what a result could mean for follow-up care. It can also help to discuss possible risks, costs, and how you might feel about different results. A prenatal clinician can explain how options fit your pregnancy and health history.

At Raveco Medical, pregnancy care is part of comprehensive obstetrics and gynecology services in Queens, NY. Your prenatal clinician or a genetic counselor can help you consider the information alongside your circumstances, values, and preferences, without pressure to choose a particular path.